Schrödinger, Inc., 120 West 45th Street, 29th Floor, New York, NY 10036, USA.
J Comput Aided Mol Des. 2009 Aug;23(8):541-54. doi: 10.1007/s10822-009-9268-1. Epub 2009 May 7.
We have developed a method that uses energetic analysis of structure-based fragment docking to elucidate key features for molecular recognition. This hybrid ligand- and structure-based methodology uses an atomic breakdown of the energy terms from the Glide XP scoring function to locate key pharmacophoric features from the docked fragments. First, we show that Glide accurately docks fragments, producing a root mean squared deviation (RMSD) of <1.0 A for the top scoring pose to the native crystal structure. We then describe fragment-specific docking settings developed to generate poses that explore every pocket of a binding site while maintaining the docking accuracy of the top scoring pose. Next, we describe how the energy terms from the Glide XP scoring function are mapped onto pharmacophore sites from the docked fragments in order to rank their importance for binding. Using this energetic analysis we show that the most energetically favorable pharmacophore sites are consistent with features from known tight binding compounds. Finally, we describe a method to use the energetically selected sites from fragment docking to develop a pharmacophore hypothesis that can be used in virtual database screening to retrieve diverse compounds. We find that this method produces viable hypotheses that are consistent with known active compounds. In addition to retrieving diverse compounds that are not biased by the co-crystallized ligand, the method is able to recover known active compounds from a database screen, with an average enrichment of 8.1 in the top 1% of the database.
我们开发了一种方法,利用基于结构的片段对接的能量分析来阐明分子识别的关键特征。这种混合配体和基于结构的方法使用 Glide XP 评分函数的能量项的原子分解,从对接的片段中定位关键药效特征。首先,我们表明 Glide 可以准确对接片段,使最高得分构象与天然晶体结构的均方根偏差 (RMSD) <1.0 A。然后,我们描述了为生成探索结合位点每个口袋的构象而开发的片段特异性对接设置,同时保持最高得分构象的对接准确性。接下来,我们描述了如何将 Glide XP 评分函数的能量项映射到对接片段的药效特征位点上,以对它们的结合重要性进行排序。使用这种能量分析,我们表明最具能量优势的药效特征位点与已知紧密结合化合物的特征一致。最后,我们描述了一种使用片段对接中能量选择的位点来开发药效假说的方法,该方法可用于虚拟数据库筛选以检索不同的化合物。我们发现该方法产生了可行的假说,与已知的活性化合物一致。除了检索不受共晶配体影响的多样化化合物外,该方法还能够从数据库筛选中恢复已知的活性化合物,在数据库的前 1%中平均富集 8.1 倍。